A Study to Evaluate Endoscope-assisted, Minimally-invasive Cortical Access System for Chronic Subdural Evacuation
NCT04502745 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2024-05-10
Summary
The purpose of this study is to evaluate a less-invasive alternative to the currently available method of removing aging blood in the subdural space.
Conditions
- Chronic Subdural Hematoma
Interventions
- DEVICE
-
Minimally Invasive Cortical Access System (MICAS)
Temporary surgical tool that provides access to the sub-dural space through the cranium.
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Jamie Van Gompel, MD · Mayo Clinic
Study Design
- Allocation
- NA
- Purpose
- DEVICE_FEASIBILITY
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-10-01
- Primary Completion
- 2023-10-23
- Completion
- 2023-10-23
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion
NCT04548843 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Phase I Open Label Dose Escalation Trial of RNA-144101 in the Treatment of Geographic Atrophy
NCT01093170 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of miRNA Expression Pattern as Diagnostic and Prognostic Biomarker in Amyotrophic Lateral Sclerosis
NCT01992029 ·Status: TERMINATED
-
MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD)
NCT02410239 ·Status: WITHDRAWN ·Phase: PHASE1
-
Clinical Procedures to Support Research in ALS
NCT03489278 ·Status: RECRUITING
-
Mesenchymal Stem Cell Therapy in Multiple System Atrophy
NCT02315027 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Mesenchymal Stem Cell Injection in Amyotrophic Lateral Sclerosis
NCT02116634 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Sedation During Muscle Biopsy in Patients With Duchenne Muscular Dystrophy
NCT01645098 ·Status: COMPLETED ·Phase: NA
-
Study of Two Intrathecal Doses of Autologous Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis
NCT02917681 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Safety, Tolerability, and Efficacy of SRP-9004 Administered by Systemic Infusion in Limb Girdle Muscular Dystrophy Type 2D/R3 Participants in the United States
NCT06747273 ·Status: TERMINATED ·Phase: PHASE1
-
Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis
NCT06391645 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Study of ALS Reversals 2: Genetic Analyses
NCT03464903 ·Status: COMPLETED
-
Cervical Spinal Cord Metabolism and Microstructure in Amyotrophic Lateral Sclerosis(ALS)
NCT02000713 ·Status: TERMINATED ·Phase: NA
-
Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients
NCT02196467 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis
NCT01082653 ·Status: SUSPENDED ·Phase: PHASE1
-
Assessment of Safety and Acute Effects of a Knee-hip Powered Soft Exoskeleton in Patients With Neuromuscular Disorders
NCT05200702 ·Status: COMPLETED ·Phase: NA
-
A Study of mRNA-3745 in Adult and Pediatric Participants With Glycogen Storage Disease Type 1a (GSD1a)
NCT05095727 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)
NCT02478450 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
NCT01730716 ·Status: UNKNOWN ·Phase: PHASE2
-
Dose-Escalation, Safety and Pharmacokinetic Study of IC14 in Motor Neurone Disease
NCT03487263 ·Status: COMPLETED ·Phase: PHASE1
-
Cortico-Spinal tDCS as Rehabilitative Intervention in Amyotrophic Lateral Sclerosis
NCT04293484 ·Status: COMPLETED ·Phase: NA
-
Neurologic Stem Cell Treatment Study
NCT02795052 ·Status: RECRUITING ·Phase: NA
-
Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)
NCT01037309 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Modeling Amyotrophic Lateral Sclerosis With Fibroblasts
NCT06450691 ·Status: RECRUITING ·Phase: NA
-
Therapeutic Treatment of Amyotrophic Lateral Sclerosis
NCT02881476 ·Status: UNKNOWN ·Phase: PHASE1